Cytosorbents Cor (CTSO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,685 | 8,459 | 8,608 | 14,131 | 8,359 |
| Receivables | 6,633 | 7,823 | 6,765 | 6,057 | 6,179 |
| Inventories | 3,248 | 4,317 | 3,739 | 3,376 | 2,977 |
| TOTAL | $16,597 | $21,955 | $19,993 | $25,399 | $19,261 |
| Non-Current Assets | |||||
| PPE Net | 9,270 | 9,424 | 9,749 | 10,056 | 10,282 |
| Other Non-Current Assets | 21,937 | 22,048 | 17,329 | 17,501 | 18,032 |
| TOTAL | $31,207 | $31,472 | $27,078 | $27,558 | $28,314 |
| Total Assets | $47,804 | $53,427 | $47,071 | $52,956 | $47,575 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,500 | 2,500 | 833 |
| Accounts payable and accrued liabilities | 2,338 | 3,047 | 2,399 | 3,802 | 3,442 |
| Accrued Expenses | 5,660 | 6,877 | 8,132 | 7,360 | 7,580 |
| TOTAL | $8,430 | $10,336 | $13,424 | $14,036 | $11,972 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,806 | 13,673 | 1,929 | 2,543 | 4,199 |
| Other Non-Current Liabilities | 12,569 | 12,681 | 12,790 | 12,897 | 12,892 |
| TOTAL | $26,375 | $26,354 | $14,719 | $15,440 | $17,091 |
| Total Liabilities | $34,805 | $36,690 | $28,143 | $29,475 | $29,063 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,680 | 54,430 | 54,306 | 54,294 | 44,439 |
| Common Shares | 55 | 54 | 54 | 54 | 44 |
| Retained earnings | -295,340 | -293,006 | -288,863 | -283,290 | -276,670 |
| Other shareholders' equity | -157 | 2,174 | 1,752 | 529 | 2,984 |
| TOTAL | $12,999 | $16,737 | $18,928 | $23,481 | $18,512 |
| Total Liabilities And Equity | $47,804 | $53,427 | $47,071 | $52,956 | $47,575 |